DIVIDEND ANNOUNCEMENT: Sr Nt/Harrow Health Inc (NASDAQ:HROWM) on 04/03/2024 declared a dividend of $0.7422 per share

Sr Nt/Harrow Health Inc (NASDAQ:HROWM) on 04/03/2024 declared a dividend of $ 0.7422 per share payable on April 30, 2024 to shareholders of record as of April 15, 2024.

Sr Nt/Harrow Health Inc (NASDAQ:HROWM) has paid dividends since 2023, has a current dividend yield of 11.1444654465% and has increased its dividends for 0 successive years.

The stock price closed yesterday at $ 26.65 and has a 52 week low/high of $ 22.71 and $ 27.72.

Harrow Health is an ophthalmic-focused pharmaceutical company. Co. engages in the development, production, sale and distribution of prescription medications. Co. owns and operates ImprimisRx, the ophthalmology-focused pharmaceutical-compounding business, and its branded drugs are marketed under its Harrow name. In addition, Co. also has non-controlling equity positions in Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures.

For more information on Sr Nt/Harrow Health Inc click here.